{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:06:23Z","timestamp":1788980783099,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmic Physiol. Opt."],"DOI":"10.1007\/s44402-026-00184-3","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:16:06Z","timestamp":1788977766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Contamination Rates and Economic Evaluation of Reusing Medicated, Preservative-Free, Single-Use Eye Drops"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9068-2513","authenticated-orcid":false,"given":"Ahmed M. Y.","family":"Osman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Gamal","family":"Tahoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhan","family":"Abdalkader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9383-0561","authenticated-orcid":false,"given":"Mohammed","family":"Aljarousha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Mahmoud","family":"Zawrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5322-3038","authenticated-orcid":false,"given":"Hanzada T.","family":"Nour El-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"184_CR1","first-page":"2","volume":"59","author":"MC Coroi","year":"2015","unstructured":"Coroi MC, Bungau S, Tit M. Preservatives from the eye drops and the ocular surface. Rom J Ophthalmol. 2015;59:2\u20135. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27373107.","journal-title":"Rom J Ophthalmol"},{"key":"184_CR2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/J.1755-3768.2008.01250.X","volume":"86","author":"C Baudouin","year":"2008","unstructured":"Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol. 2008;86:716\u201326. https:\/\/doi.org\/10.1111\/J.1755-3768.2008.01250.X.","journal-title":"Acta Ophthalmol"},{"key":"184_CR3","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1345\/aph.1R229","volume":"46","author":"C Swymer","year":"2012","unstructured":"Swymer C, Neville MW. Tafluprost: the first preservative-free prostaglandin to treat open-angle glaucoma and ocular hypertension. Ann Pharmacother. 2012;46:1506\u201310. https:\/\/doi.org\/10.1345\/aph.1R229.","journal-title":"Ann Pharmacother"},{"key":"184_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40261-014-0203-4","volume":"34","author":"M Sanford","year":"2014","unstructured":"Sanford M. Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma\/ocular hypertension. Clin Drug Investig. 2014;34:521\u20138. https:\/\/doi.org\/10.1007\/s40261-014-0203-4.","journal-title":"Clin Drug Investig"},{"key":"184_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF00184009","volume":"232","author":"C de Jong","year":"1994","unstructured":"de Jong C, Stolwijk T, Kuppens E, de Keizer R, van Best J. Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma. Graefe\u2019s Arch Clin Exp Ophthalmol. 1994;232:221\u20134. https:\/\/doi.org\/10.1007\/BF00184009.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"184_CR6","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/bjo.86.4.418","volume":"86","author":"PJ Pisella","year":"2002","unstructured":"Pisella PJ. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol. 2002;86:418\u201323. https:\/\/doi.org\/10.1136\/bjo.86.4.418.","journal-title":"Br J Ophthalmol"},{"key":"184_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.aopr.2022.100046","volume":"2","author":"S Chantra","year":"2022","unstructured":"Chantra S, Hathaisaard P, Grzybowski A, Ruamviboonsuk P. Microbial contamination of multiple-dose preservative-free hospital ophthalmic preparations in a tertiary care hospital. Adv Ophthalmol Pract Res. 2022;2:100046. https:\/\/doi.org\/10.1016\/j.aopr.2022.100046.","journal-title":"Adv Ophthalmol Pract Res"},{"key":"184_CR8","doi-asserted-by":"publisher","unstructured":"Tamrat L, Gelaw Y, Beyene G, Gize A. Microbial contamination and antimicrobial resistance in use of ophthalmic solutions at the Department of Ophthalmology, Jimma University Specialized Hospital, Southwest Ethiopia. Can J Infect Dis Med Microbiol. 2019;2019. https:\/\/doi.org\/10.1155\/2019\/5372530","DOI":"10.1155\/2019\/5372530"},{"key":"184_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0002-9394(88)90298-X","volume":"105","author":"PJ Wasson","year":"1988","unstructured":"Wasson PJ, Boruchoff SA, Schein OD, Kenyon KR. Microbial keratitis associated with contaminated ocular medications. Am J Ophthalmol. 1988;105:361\u20135. https:\/\/doi.org\/10.1016\/0002-9394(88)90298-X.","journal-title":"Am J Ophthalmol"},{"key":"184_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/OPTH.S109247","volume":"11","author":"R Ratnumnoi","year":"2017","unstructured":"Ratnumnoi R, Keorochana N. Sontisombat C. Normal flora of conjunctiva and lid margin, as well as its antibiotic sensitivity, in patients undergoing cataract surgery at Phramongkutklao Hospital. Clin Ophthalmol. 2017;11:237\u201341. https:\/\/doi.org\/10.2147\/OPTH.S109247.","journal-title":"Clin Ophthalmol"},{"key":"184_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3390\/pathogens11050592","volume":"11","author":"JH Lee","year":"2022","unstructured":"Lee JH, Kang MJ, Sim HE, Hwang JH. Microbial contamination of preservative-free artificial tears based on instillation techniques. Pathogens. 2022;11:592 https:\/\/doi.org\/10.3390\/pathogens11050592.","journal-title":"Pathogens"},{"key":"184_CR12","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1136\/BJO.2008.144469","volume":"92","author":"MS Kim","year":"2008","unstructured":"Kim MS, Choi CY, Kim JM, Chung HR, Woo HY. Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers. Br J Ophthalmol. 2008;92:1518\u201321. https:\/\/doi.org\/10.1136\/BJO.2008.144469.","journal-title":"Br J Ophthalmol"},{"key":"184_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/BJO.2005.078386","volume":"90","author":"MQ Rahman","year":"2006","unstructured":"Rahman MQ, Tejwani D, Wilson JA, Butcher I, Ramaesh K. Microbial contamination of preservative free eye drops in multiple application containers. Br J Ophthalmol. 2006;90:139 https:\/\/doi.org\/10.1136\/BJO.2005.078386.","journal-title":"Br J Ophthalmol"},{"key":"184_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics14102176","volume":"14","author":"K Iskandar","year":"2022","unstructured":"Iskandar K, Marchin L, Kodjikian L, Rocher M, Roques C. Highlighting the microbial contamination of the dropper tip and cap of in-use eye drops, the associated contributory factors and the risk of infection: a past-30-years literature review. Pharmaceutics. 2022;14:1\u201327. https:\/\/doi.org\/10.3390\/pharmaceutics14102176.","journal-title":"Pharmaceutics"},{"key":"184_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/eye.2013.187","volume":"27","author":"AJ Tatham","year":"2013","unstructured":"Tatham AJ, Sarodia U, Gatrad F, Awan A. Eye drop instillation technique in patients with glaucoma. Eye. 2013;27:1293\u20138. https:\/\/doi.org\/10.1038\/eye.2013.187.","journal-title":"Eye"},{"key":"184_CR16","doi-asserted-by":"publisher","unstructured":"Crary M. A review of the containers available for multi-dose preservative-free eye drops. Biomed J Sci Tech Res. 2022;45:36035\u201344. https:\/\/doi.org\/10.26717\/bjstr.2022.45.007130.","DOI":"10.26717\/bjstr.2022.45.007130"},{"key":"184_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0939-6411(01)00246-6","volume":"53","author":"P Furrer","year":"2002","unstructured":"Furrer P, Mayer JM, Gurny R. Ocular tolerance of preservatives and alternatives. Eur J Pharm Biopharm. 2002;53:263\u201380. https:\/\/doi.org\/10.1016\/S0939-6411(01)00246-6.","journal-title":"Eur J Pharm Biopharm"},{"key":"184_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjophth-2024-001632","volume":"9","author":"FC Fierz","year":"2024","unstructured":"Fierz FC, Locher S, Bachmann L, et al. Multiple use of preservative-free single dose unit dexamethasone 0.1% eye drops is safe within 24\u2009h. BMJ Open Ophthalmol. 2024;9:1\u20137. https:\/\/doi.org\/10.1136\/bmjophth-2024-001632.","journal-title":"BMJ Open Ophthalmol"},{"key":"184_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ophtha.2015.09.005","volume":"123","author":"T Li","year":"2016","unstructured":"Li T, Lindsley K, Rouse B, et al. Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology. 2016;123:129\u201340. https:\/\/doi.org\/10.1016\/j.ophtha.2015.09.005.","journal-title":"Ophthalmology"},{"key":"184_CR20","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1517\/14656566.2011.606810","volume":"12","author":"M Papadia","year":"2011","unstructured":"Papadia M, Bagnis A, Scotto R, Traverso CE. Tafluprost for glaucoma. Expert Opin Pharmacother. 2011;12:2393\u2013401. https:\/\/doi.org\/10.1517\/14656566.2011.606810.","journal-title":"Expert Opin Pharmacother"},{"key":"184_CR21","doi-asserted-by":"publisher","unstructured":"Liu Y, Mao W. Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma. Clin Ophthalmol. 2012:7:7\u201314. https:\/\/doi.org\/10.2147\/opth.s30951.","DOI":"10.2147\/opth.s30951"},{"key":"184_CR22","first-page":"46","volume":"18","author":"TD Hyde","year":"2014","unstructured":"Hyde TD. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding. Int J Pharm Compd. 2014;18:46\u201352. https:\/\/pubmed.ncbi.nlm.nih.gov\/24881341.","journal-title":"Int J Pharm Compd"},{"key":"184_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1086\/600885","volume":"49","author":"P Seng","year":"2009","unstructured":"Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis. 2009;49:543\u201351. https:\/\/doi.org\/10.1086\/600885.","journal-title":"Clin Infect Dis"},{"key":"184_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43\u201346. https:\/\/doi.org\/10.1097\/00001648-199001000-00010.","journal-title":"Epidemiology"},{"key":"184_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jceh.2019.11.001","volume":"10","author":"N Gupta","year":"2020","unstructured":"Gupta N, Verma R, Dhiman RK, Rajsekhar K, Prinja S. Cost-effectiveness analysis and decision modelling: a tutorial for clinicians. J Clin Exp Hepatol. 2020;10:177\u201384. https:\/\/doi.org\/10.1016\/j.jceh.2019.11.001.","journal-title":"J Clin Exp Hepatol"},{"key":"184_CR26","doi-asserted-by":"publisher","unstructured":"Foster T. Staphylococcus. In: Baron S, editor. Medical microbiology. 4th ed. Galveston, Texas: University of Texas Medical Branch at Galveston; 1996. https:\/\/doi.org\/10.1201\/9781315120089-13.","DOI":"10.1201\/9781315120089-13"},{"key":"184_CR27","unstructured":"USD to EGP Exchange Rate History for 2022. https:\/\/www.exchange-rates.org\/exchange-rate-history\/usd-egp-2022. Accessed 17 Aug 2025."},{"key":"184_CR28","unstructured":"Exchange Rates Historical Data. https:\/\/www.cbe.org.eg\/en\/economic-research\/statistics\/exchange-rates\/historical-data. Accessed 17 Aug 2025."},{"key":"184_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/J.BFOPCU.2016.05.004","volume":"54","author":"AA Abdelrahman","year":"2016","unstructured":"Abdelrahman AA, Saad AA, Sabry NA, Farid SF. Perceptions of Egyptian physicians about drug shortage during political disturbances: survey in Greater Cairo. Bull Fac Pharm Cairo Univ. 2016;54:191\u20136. https:\/\/doi.org\/10.1016\/J.BFOPCU.2016.05.004.","journal-title":"Bull Fac Pharm Cairo Univ"},{"key":"184_CR30","unstructured":"Saad AA. Drug shortage in Egypt: causes and mitigation measures. AUC Knowledge Fountain, American University in Cairo, Master\u2019s Thesis. 2019. https:\/\/fount.aucegypt.edu\/etds\/1711. Accessed 17 Aug 2025."},{"key":"184_CR31","doi-asserted-by":"publisher","first-page":"693426","DOI":"10.3389\/FPHAR.2021.693426\/EPUB","volume":"12","author":"S Shukar","year":"2021","unstructured":"Shukar S, Zahoor F, Hayat K, et al. Drug shortage: causes, impact and mitigation strategies. Front Pharmacol. 2021;12:693426 https:\/\/doi.org\/10.3389\/FPHAR.2021.693426\/EPUB.","journal-title":"Front Pharmacol"}],"container-title":["Ophthalmic and Physiological Optics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44402-026-00184-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44402-026-00184-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44402-026-00184-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:16:07Z","timestamp":1788977767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44402-026-00184-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":31,"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1007\/s44402-026-00184-3","relation":{},"ISSN":["0275-5408","1475-1313"],"issn-type":[{"value":"0275-5408","type":"print"},{"value":"1475-1313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors did not use any Generative AI or AI-assisted technologies and the authors take full responsibility for the content of the publication.","order":2,"name":"Ethics","label":"Declaration of Generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}]}}